During the past decade, Harvard University (Joslin Diabetes Center) conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harvard University (Joslin Diabetes Center)" #1 collaborator was "DexCom, Inc." with 4 trials as a collaborator, "Jaeb Center for Health Research" with 4 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 4 trials as a collaborator, "Tandem Diabetes Care, Inc." with 3 trials as a collaborator and "Roche Diagnostic Ltd." with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Harvard University (Joslin Diabetes Center)" are "Type 1 Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "New-onset Type 1 Diabetes" (1 trials) and "New-onset type1 Diabetes" (1 trials). Many other conditions were trialed in "Harvard University (Joslin Diabetes Center)" in a lesser frequency.

Most popular intervention types in "Harvard University (Joslin Diabetes Center)" are "Device" (4 trials), "Drug" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Artificial Pancreas" (2 trials), "Ladarixin" (2 trials), "t:slim X2 with Control-IQ Technology & Dexcom G6 CGM" (2 trials) and "AVT001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harvard University (Joslin Diabetes Center)" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Harvard University (Joslin Diabetes Center)". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Harvard University (Joslin Diabetes Center), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Harvard University (Joslin Diabetes Center), 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".